Abeona Therapeutics, Inc.
(NASDAQ : ABEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. 1.76%160.761.9%$233.14m
MYLMylan NV 1.48%14.423.2%$81.46m
TEVATeva Pharmaceutical Industries Ltd. 1.87%8.732.0%$68.56m
RDYDr. Reddy's Laboratories Ltd. 2.77%69.642.0%$13.03m
TXMDTherapeuticsMD, Inc. 7.63%1.4122.1%$3.59m
KINKindred Biosciences, Inc. -3.25%4.470.3%$2.00m
ABEOAbeona Therapeutics, Inc. -4.62%1.864.4%$1.83m
JAGXJaguar Health, Inc. 5.34%0.311.4%$1.79m
COCPCocrystal Pharma, Inc. 2.26%0.920.0%$1.59m
TAROTaro Pharmaceutical Industries Ltd. -0.40%54.996.5%$1.46m
LFVNLifeVantage Corp. -1.04%12.423.3%$0.89m
CPHIChina Pharma Holdings, Inc. 3.91%0.380.1%$0.11m

Company Profile

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.